R. Srivastav

MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)

N. Pavlakis, L. Chantrill, C. Steer, 2021, BMC cancer.

Concurrent asynchronous robotic subsumption using actors & promises

G. Nandi, Harsh Verma, Article Info, 2019, IAES International Journal of Robotics and Automation (IJRA).